The metastatic behavior of osteosarcoma by gene expression and cytogenetic analyses

Human Pathology

Volumn 44, Issue 10, 2013, Pages 2188-2198

  Salinas Souza, Carolina ^a   De Oliveira, Renato ^a   Alves, Maria Teresa De Seixas ^a   Garcia Filho, Reynaldo Jesus ^a   Petrilli, Antonio Sergio ^a   Toledo, Silvia Regina Caminada ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cell culture; CXCR4; Fluorescence in situ hybridization; Gene expression; Lung metastasis; MDM2; Osteosarcoma

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN; PROTEIN MDM2; RB1 PROTEIN; TRANSCRIPTION FACTOR OSTERIX; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; HUMAN; LUNG METASTASIS; LUNG PARENCHYMA; MALE; OSTEOSARCOMA; OVERALL SURVIVAL; PRIMARY CULTURE; PRIMARY TUMOR; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

CELL CULTURE; CXCR4; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; LUNG METASTASIS; MDM2; OSTEOSARCOMA;

ADOLESCENT; BONE NEOPLASMS; BRAZIL; CYTOGENETIC ANALYSIS; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; OSTEOSARCOMA; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MDM2; RANK LIGAND; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CXCR4; RETINOBLASTOMA PROTEIN; SURVIVAL RATE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84884418891     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.04.013     Document Type: Article

References (35)

1. L. Mirabello, R.J. Troisi, and S.A. Savage Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program Cancer 115 2009 1531 1543
2. G. Bacci, M. Rocca, and M. Salone High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions J Surg Oncol 98 2008 415 420
3. A.S. Petrilli, B. de Camargo, and V.O. Filho Results of the Brazilian Osteosarcoma Treatment Group (BOTG) Studies III And IV: prognostic factors and impact on survival J Clin Oncol 24 2006 1161 1168
4. J.A. Joyce, and J.W. Pollard Microenvironmental regulation of metastasis Nat Rev Cancer 9 2009 239 252
5. M. Zielenska, J. Bayani, and A. Pandita Comparative genomic hybridization analysis identifies gains of 1p35 approximately p36 and chromosome 19 in osteosarcoma Cancer Genet Cytogenet 130 2001 14 21
6. F.L. Wong, J.D. Boice Jr., and D.H. Abramson Cancer incidence after retinoblastoma: radiation dose and sarcoma risk JAMA 278 1997 1262 1267
7. T. Katagiri, and N. Takahashi Regulatory mechanisms of osteoblast and osteoclast differentiation Oral Dis 8 2002 147 159
8. T. Iwakuma, and G. Lozano MDM2, an introduction Mol Cancer Res 1 2003 993 1000
9. K. Nakashima, X. Zhou, and G. Kunkel The novel zinc finger-containing transcription factor OSTERIX is required for osteoblast differentiation and bone formation Cell 108 2002 17 29
10. A.F. Chambers, A.C. Groom, and I.C. MacDonald Dissemination and growth of cancer cells in metastatic sites Nat Rev Cancer 2 2002 563 572
11. J. Atiye, M. Wolf, and S. Kaur Gene amplifications in osteosarcoma-CGH microarray analysis Genes Chromosomes Cancer 42 2005 158 163
12. G. Lim, J. Karaskova, and B. Beheshti An integrated mBAND and submegabase resolution tiling set (SMRT) CGH array analysis of focal amplification, microdeletions, and ladder structures consistent with breakage-fusion-bridge cycle events in osteosarcoma Genes Chromosomes Cancer 42 2005 392 403
13. D.L. Burkhart, and J. Sage Cellular mechanisms of tumour suppression by the retinoblastoma gene Nat Rev Cancer 8 2008 671 682
14. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 2001 402 408
15. B. Psaila, and D. Lyden The metastatic niche: adapting the foreign soil Nat Rev Cancer 9 2009 285 293
16. J. PosthumaDeBoer, M.A. Witlox, G.J. Kaspers, and B.J. van Royen Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature Clin Exp Metastasis 28 2011 493 503
17. B. Sosa-García, V. Gunduz, and V. Vázquez-Rivera A role for the retinoblastoma protein as a regulator of mouse osteoblast cell adhesion: implications for osteogenesis and osteosarcoma formation PLoS One 5 2010 e13954
18. B. Sadikovic, P. Thorner, and S. Chilton-Macneill Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy BMC Cancer 10 2010 202
19. B.P. Pereira, Y. Zhou, and A. Gupta Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1) J Cell Physiol 221 2009 778 788
20. S.R. Toledo, I.D. Oliveira, and O.K. Okamoto Bone deposition, bone resorption, and osteosarcoma J Orthop Res 28 2010 1142 1148
21. J.A. Lee, J.S. Jung, and D.H. Kim RANKL expression is related to treatment outcome of patients with localized, high-grade osteosarcoma Pediatr Blood Cancer 56 2011 738 743
22. M.B. Mintz, R. Sowers, and K.M. Brown An expression signature classifies chemotherapy resistant pediatric osteosarcoma Cancer Res 65 2005 1748 1754
23. L. Endo-Munoz, A. Cumming, S. Sommerville, I. Dickinson, and N.A. Saunders Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone Br J Cancer 103 2010 73 81
24. L. Endo-Munoz, A. Cumming, and D. Rickwood Loss of osteoclasts contributes to development of osteosarcoma pulmonary metastases Cancer Res 70 2010 7063 7072
25. C. Laverdiere, B.H. Hoang, and R. Yang Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma Clin Cancer Res 11 2005 2561 2567
26. S.Y. Kim, C.H. Lee, and B.V. Midura Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases Clin Exp Metastasis 25 2008 201 211
27. R.N. Kaplan, R.D. Riba, and S. Zacharoulis VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche Nature 8 2005 820 827
28. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill Cancer-related inflammation Nature 454 2008 436 444
29. D.K. Jin, K. Shido, and H.G. Kopp Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes Nat Med 12 2006 557 567
30. C.J. Lengner, H.A. Steinman, and J. Gagnon Osteoblast differentiation and skeletal development are regulated by MDM2-p53 signaling J Cell Biol 172 2006 909 921
31. J. Weaver, E. Downs-Kelly, and J.R. Goldblum Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms Mod Pathol 21 2008 943 949
32. M. Ladanyi, C. Cha, R. Lewis, S.C. Jhanwar, A.G. Huvos, and J.H. Healey MDM2 gene amplification in metastatic osteosarcoma Cancer Res 53 1993 16 18
33. B. McClintock The stability of broken ends of chromosomes in Zea mays Genetics 26 1941 234 282
34. L.A. Duhamel, H. Ye, and D. Halai Frequency of Mouse Double Minute 2 (MDM2) and Mouse Double Minute 4 (MDM4) amplification in parosteal and conventional osteosarcoma subtypes Histopathology 60 2012 357 359
35. C. Tovar, J. Rosinski, and Z. Filipovic Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy Proc Natl Acad Sci 103 2006 1888 1893